The STEP trials demonstrated that semaglutide users achieved an average 1015% body weight reduction over 68 weeks, with some patients losing up to 22% of their starting weight
The median weight of participants was 85 kg (IQR: 7399), the median height was 163 cm (IQR: 158174), and the median BMI was 31.2 kg/m 2 (IQR: 27.635.8), suggesting a predominantly overweight or obese cohort
Compounded semaglutide drugs may use the salt form of the hormone, including semaglutide sodium and semaglutide acetate
"Azithromycin for cystic fibrosis"
Semaglutide, primarily used for managing type 2 diabetes and aiding weight loss, raises concerns among patients and healthcare providers regarding potential liver damage
And this is why consuming antioxidants regularly is so important